Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics Approach

VRC01 is a first-in-class, potent, broadly neutralizing antibody that targets the CD4 binding site of gp120 on HIV-1 viruses, and is under development as a novel HIV therapeutic. This study utilized population pharmacokinetic modeling to characterize VRC01 pharmacokinetics to guide dosing selection...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Pharmacol Ther
Hlavní autoři: Li, Jerry, Nikanjam, Mina, Cunningham, Coleen K., McFarland, Elizabeth J., Coates, Emily E., Houser, Katherine V., Lin, Bob C., McDermott, Adrian B., Flach, Britta, Gama, Lucio, Koup, Richard A., Graham, Barney S., Mascola, John R., Ledgerwood, Julie E., Capparelli, Edmund V.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7902301/
https://ncbi.nlm.nih.gov/pubmed/32866318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.2026
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky